20th World Congress of Dermatology
?
Poster abstracts Thursday 4th July - Friday 5th July 2002 Pharmacology and drug therapy P1635 Garlic lotion: a new remedy for pediculosis capitis P1636 The effects of orally administered terbinafine on sebum composition P1637 Leucocytoclastic vasculitis with type I cryoglobulinemia treated with plasmapheresis P1638 Stevens-Johnson syndrome succeeded by toxic epidermal necrolysis treated with aciclovir P1639 Computational chemistry studies on pimecrolimus (SDZ ASM 981) and tacrolimus (FK 506) reveal major differences in surface lipophilicity patterns P1640 Intralesional betamethasone in granuloma faciale P1641 Neurogenic inflammation induced by neuropeptides in an organ culture of human skin P1642 Significance of a skin care product in preventing neurogenic inflammation P1643 Regression of basal cell carcinoma induced by topical tazarotene P1644 Evaluation of skin kinetics of metronidazole and its hydroxymetabolite after a single oral dose assessed by cutaneous microdialysis P1645 Pimecrolimus (SDZ ASM 981) is more lipophilic and permeates less through skin than Tacrolimus (FK 506) P1646 Pimecrolimus (SDZ ASM 981) permeates less through skin than topical corticosteroids P1647 Homeopathic Thuja Occidentalis vs Placebo in Common Warts P1648 Raloxifen in postmenopausal changes in dermal collagen P1649 Successful use of infliximab in a patient with graft versus host disease P1650 Cancelled by the author P1651 Treatment of angiosarcoma of the scalp by intraarterial pegylated, liposomal doxorubicin (Caelyx?) and intralesional pegylated interferon-a (Pegintron?) P1652 Fabry disease: enzyme replacement therapy P1653 Immunomodulatory properties of polypodium leucotomos extract (Difur) P1654 Inhibitory activity of hydrophilic extract of polypodium leucotomos (HPLE) of erythema mediated by ultraviolet B radiation P1655 A case of idiopathic lobular panniculitis successfully treated with mycophenolate mofetil monotherapy P1656 How botulinum a toxin modifies life quality of patients suffering from focal severe hyperhidrosis P1657 Topical imiquimod is non-toxic P1658 Effective treatment of subcorneal pustular dermatosis with cyclosporine P1659 Prognosis of severe alopecia areata is significantly affected by treatment with squaric acid dibutylester (SADBE): a case control study P1660 Botulinum toxin for palmar and axillary hyperhidrosis. Quality of life assessment P1661 Evaluation of depigmentating effects of skin care products using human tanned epidermis reconstituted in vitro in chemically defined medium P1662 An open label pilot study to investigate the efficacy of tacrolimus 0.1% ointment for the treatment of seborrheic dermatitis P1663 Wilprafen in the treatment of dermatitis perioralis and rosacea P1664 Lithium vs ketoconazole in seborrheic dermatitis: a multicenter, randomized, controlled study P1665 Aloe vera plant: its uses in dermatology P1666 Aloe arborescens extract, biochemical characterization and comparative differences against Aloe vera P1667 Comparison of ketotifen effectiveness with hydroxyzine in the treatment of pruritus and chronic idiopatic urticaria P1668 Treatment of striae and scars with mandelic acid P1669 Topical immunotherapy of refractory alopecia areata with diphencyprone P1670 Ketamine: a therapeutic alternative in pruritus P1671 Cyclosporin in the treatment of severe mucocutaneous drug-induced reactions P1672 Granulocytic stimulating growth factor colony as treatment in vascular leg ulcers P1673 Calcipotriol in the treatment of vitiligo P1674 Botulinum toxin a for treatment of palmar hyperhidrosis P1675 Non-psoriatic uses of calcipotriol P1676 Topical anti-IL-8 antibody: effect on murine allergic contact dermatitis P1677 Influence of nonresponders in UV-erythema test for corticosteroids P1678 Penetration of [14C]-econazole into the human nail plate P1679 Infliximab in the treatment of panniculitis P1680 Two cases of peeling skin syndrome: is acitretin an effective treatment? P1681 7-year follow-up of Kapos?s sarcoma (classical type) treated with low doses of interferon alpha-2A P1682 Pimecrolimus (SDZ ASM 981) does not affect the expression of surface markers and functions of dendritic cells, in contrast to corticosteroids P1683 Granulocyte and monocyte adsorption apheresis for skin disorders P1684 Treatment of erosive lichen planus of the penis with topical tacrolimus P1685 Cloxacillin concentration measurement by gas chromatography mass spectrometry P1686 Study on pharmacodynamics of Rhizoma Zedoariae oil cream P1687 A study on treating eczema with Chinese herbal medicine P1688 Activity of oral terbinafine in seborrhea P1689 A new way for a new classification of topical corticosteroids P1690 Pimecrolimus (SDZ ASM 981) cream equals tacrolimus (FK 506) ointment in efficacy in porcine allergic contact dermatitis P1691 Pimecrolimus (SDZ ASM 981) does not affect Langerhans' cells in murine epidermis, in contrast to corticosteroids P1692 Pimecrolimus (SDZ ASM 981) and tacrolimus (FK 506) target skin and peripheral lymphoid organs differently in mice and rats P1693 Hydroa vacciniforme: dietary fish oil (Maxepa?) as an effective treatment P1694 Proteus syndrome P1695 Intermittent pressure inhibits human keratinocyte proliferation in vitro P1696 Clarithromycin based intermittent chemotherapy for "MB" leprosy - preliminary observations P1697 Effect of terbinafine on desipramine pharmacokinetics in extensive CYP2D6 metabolisers P1698 Leflunomide: first experience in treatment of psoriasis arthropica (PSA) P1699 Skin biopsy analysis of psoriasis patients treated with oral pimecrolimus (SDZ ASM 981) confirms reversal of disease phenotype to normal P1700 Slow internal release of bioactive compounds under the effect of skin enzymes P1701 Effects of momethasone furoate cream 0.1% on the epidermal barrier function P1702 Anti-inflammatory activity of desloratadine: A pilot study P1703 Enoxaparine in lichen planus P1704 Imiquimod: Remarkable therapy for vascular lesions P1705 Pimecrolimus (SDZ ASM 981) has high affinity for the skin: a tissue distribution study in rats in comparison with tacrolimus (FK 506) P1706 Thymol-bifonazole formulation in absolute ethanol for treatment of Candida paronychia P1707 Treatment of palmar hyperhidrosis with botulinum toxin P1708 Therapy of genital candidiases with itraconazole P1709 N-acetyltransferase polymorphism in patients with systemic lupus erythematosus P1710 Cutaneous hyperpigmentation of the face, only manifestation of porphyria cutanea tarda in a hepatitis C positive patient P1711 Infliximab for the treatment of hidradenitis suppurativa P1712 Crystalline study of CO3H-, Mg2+ and Ca2+ deposits following evaporation of an aqueous solution P1713 Er: YAG laser assisted percutaneous drug delivery P1714 An extract of polypodium leucotomos (ple/difur) exhibits potent immunologically-mediated antioxidant activities in several models of UV irradiation P1715 Percutaneous penetration of various metronidazole formulations in human skin P1716 Effects of pimecrolimus (SDZ ASM 981) and tacrolimus on cytokine expression of stimulated human T-cell line (Jurkat) measured via PCR and ELISA P1717 The use-(ultrasound-erythema-) index in anti-psoriatic drug testing P1718 Microemulsions containing cyclosporin a for topical therapy of plaque-type psoriasis P1719 Topical application of drug delivery systems containing glycopyrroniumbromide in localized hyperhidrosis P1720 Skin kinetics activity of the psoralen evaluated by photobiology investigation					1st TO 5th JULY 2002 PARIS Back to main menu Foreword Oral communications and co-opted speakers abstracts Poster abstracts Searching by Author's name Searching by Article's number

?